Global Cardiometabolic Drugs Industry Poised for Steady Growth at 4-5% CAGR, Reaching US$70 Billion by 2032 | FMI Analysis
The Global Cardiometabolic Drugs Industry is on track for sustained expansion, fueled by the rising
Global Cardiometabolic Drugs Industry Set to Surpass US$ 70 Billion Mark by 2032, Propelled by a Steady CAGR of 4% to 5% | FMI
In a groundbreaking revelation, the Global Cardiometabolic Drugs Industry is on the brink of an